Hepatocellular Carcinoma (HCC) represents the fifth most common malignancy and the third cancer-related cause of death worldwide. Liver transplantation (LT) is an excellent treatment for patients with small HCC associated with cirrhosis. The purpose of this review is to investigate the possible strategies for the treatment of HCC recurrence after LT based on current clinical evidence.
Multimodal oncological approach in patients affected by recurrent hepatocellular carcinoma after liver transplantation / Guerrini, Gp; Berretta, M; Tarantino, G; Magistri, P; Pecchi, A; Ballarin, R; Di Benedetto, F. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 2284-0729. - 21:15(2017), pp. 3421-3435.
Multimodal oncological approach in patients affected by recurrent hepatocellular carcinoma after liver transplantation
Magistri P;
2017
Abstract
Hepatocellular Carcinoma (HCC) represents the fifth most common malignancy and the third cancer-related cause of death worldwide. Liver transplantation (LT) is an excellent treatment for patients with small HCC associated with cirrhosis. The purpose of this review is to investigate the possible strategies for the treatment of HCC recurrence after LT based on current clinical evidence.| File | Dimensione | Formato | |
|---|---|---|---|
|
Guerrini_Multimodal_2017.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
512.23 kB
Formato
Adobe PDF
|
512.23 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
